Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Go® Insulin Delivery Device
May 17, 2022 06:04 ET | Zealand Pharma
Company announcement – No. 21 / 2022 Zealand Pharma Announces Asset Purchase Agreement with MannKind Corporation for V-Go® Insulin Delivery Device Deal includes $10 million USD upfront payment to...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities [CORRECTED]
May 12, 2022 16:05 ET | Zealand Pharma
Company announcement – No. 20/ 2022 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities [CORRECTED] Copenhagen, DK and Boston, MA, May 12, 2022 –...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities
May 12, 2022 12:05 ET | Zealand Pharma
Company announcement – No. 19 / 2022 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities Copenhagen, DK and Boston, MA, May 12, 2022 – Zealand Pharma...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022
May 10, 2022 16:05 ET | Zealand Pharma
Company announcement – No. 17 / 2022 Zealand Pharma major shareholder announcement: Credit Suisse Group AG, 2022 Copenhagen, DK and Boston, MA, May 10 2022 – Zealand Pharma A/S (“Zealand”)...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Zealand Pharma Amends Financing Agreement with Oberland Capital as Part of Company’s Refocused Strategy
May 09, 2022 21:17 ET | Zealand Pharma
Company announcement – No. 16/ 2022 Zealand Pharma Amends Financing Agreement with Oberland Capital as Part of Company’s Refocused Strategy Amendment reduces the outstanding note principal balance...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10am ET) to Present First Quarter Results for 2022
May 05, 2022 04:00 ET | Zealand Pharma
Company announcement – No. 15 / 2022 Zealand Pharma Hosts Conference Call on May 12 at 4 pm CET (10am ET) to Present First Quarter Results for 2022 Copenhagen, DK and Boston, MA, U.S. May 5,...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities
April 22, 2022 11:00 ET | Zealand Pharma
Company announcement – No. 15 / 2022 Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilities Copenhagen, DK and Boston, MA, April 22, 2022 – Zealand Pharma...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors for 2022
April 20, 2022 16:30 ET | Zealand Pharma
Company announcement – No. 14 / 2022 Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors for 2022 Copenhagen, DK and Boston, MA, US., April 20, 2022 – Zealand Pharma...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Correction: Zealand Pharma major shareholder announcement: Polar Capital LLP, April 7 2022
April 07, 2022 10:18 ET | Zealand Pharma
Company announcement – No. 13 / 2022 CORRECTION: Zealand Pharma major shareholder announcement: Polar Capital LLP, April 7 2022 Copenhagen, DK and Boston, MA, April 7, 2022 – Zealand Pharma A/S...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Zealand Pharma major shareholder announcement: The Capital Group Companies, April 7 2022
April 07, 2022 03:00 ET | Zealand Pharma
Company announcement – No. 13 / 2022 Zealand Pharma major shareholder announcement: The Capital Group Companies, April 7 2022 Copenhagen, DK and Boston, MA, April 7, 2022 – Zealand Pharma A/S...